Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Provider- and system-level barriers to surveillance for hepatocellular carcinoma among patients with chronic liver disease.
Authors
Eliza W. Beal
Ohio State University Comprehensive Cancer Center, Columbus, OH
Eliza W. Beal , Leva Gorji , Jaclyn Volney , Lindsey Sova , Allan Tsung , Ann Scheck McAlearney
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
DOI
10.1200/JCO.2022.40.4_suppl.404
Abstract #
404
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Multi-target blood test to improve the performance of hepatocellular carcinoma surveillance programs: A modeling-based virtual trial.
First Author: Jagpreet Chhatwal
Poster
2020 Gastrointestinal Cancers Symposium
The adherence to The American Association for The Study of Liver Disease (AASLD) guidelines in treating patients with hepatocellular carcinoma: Institutional experience.
First Author: Ashish Manne
Poster
2016 Gastrointestinal Cancers Symposium
Phase II study of individualized adaptive stereotactic body radiotherapy (SBRT) for patients at high risk for liver damage.
First Author: Mary Uan-Sian Feng
Poster
2012 Gastrointestinal Cancers Symposium
Treating chronic hepatitis in Asian and Pacific island populations: A comparison of program costs according to current treatment guidelines.
First Author: Monica Cristina Robotin